PRISMA 2020: An Update

In this space, some 10 years ago, I wrote about the relatively new Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement, a set of guidelines that were released to provide more sophisticated uniform standards reporting integrated literature or systematic reviews (Swartz, 2011Swartz M.K. The PRISMA statement: A guideline meta-analyses.Journal Pediatric Health Care. 2011; 25: 1-2Abstract Full Text PDF PubMed Scopus (128) Google Scholar). Since then, editorial has been widely cited. Moreover, revised 2020 statement (Page et al., 2021Page M.J. McKenzie J.E. Bossuyt P.M. Boutron I. Hoffmann T.C. Mulrow C.D. Moher D. An updated reviews.The British Medical Journal. 2021; 372: n71Crossref (2284) Scholar) now released, so thought it might be wise visit topic again. in health care remain important as means keeping clinicians up date on advances their fields, providing basis clinical practice guidelines, identifying research questions, prioritizing needs funding. are not intended necessarily guide conduct type research. Rather, is recommended assist authors clear, accurate, complete documentation review process findings. original from 2009 have endorsed by over 200 journals various disciplines (Moher 2009Moher Liberati A. Tetzlaff J. Altman D.G. GroupPreferred items meta-analyses: Statement.Annals Internal Medicine. 2009; 151 (W64): 264-269Crossref (15323) Scholar; Page 2009, there developments conducting reviews, including methods determine possibility bias reviewed studies. There also how results may disseminated, data materials easily shared publicly accessible repositories. addition, strategies identified facilitate implementation guidelines. For these reasons, through exhaustive surveys, iterative discussions, Similar contains 27-item checklist with detailed recommendations, an abstract checklist, flow diagram Among updates (1) presenting full search all databases used, (2) enhancing records reviewed, (3) using additional subitems sections clearer synthesis results, (4) minimizing risk among studies, (5) degree confidence evidence related outcome, (6) declaring any competing interests authors, (7) whether analytic codes available. To help track which report within manuscript, Web site (PRISMA, 2021PRISMATransparet Systematic.Reviews Meta Analyses. (Available at:)http://www.prisma-statement.orgGoogle http://www.prisma-statement.org fillable templates user-friendly interface, well helpful, chart. Although seem like daunting undertaking, offer concrete steps pathways enhance such projects. hope will continue benefit editors, manuscript reviewers, developers, providers, patients. Martha K. Swartz, Editor-in-Chief, Journal Care, Yale School Nursing, University, West Haven, CT